Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Lidiane Inês Da Rosa, MD, Wellington Fernandes da Silva, MD, Andre Abdo, MD, Eduardo M Rego, MD PhD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2019) 134 (Supplement_1): 5284.

https://doi.org/10.1182/blood-2019-126307

Published: 2019

Journal Articles

Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

Elisa Quiroz, MD, Rebecca Nelson, MD, Vinod A. Pullarkat, MD, Ibrahim Aldoss, Thomas Slavin, MD, Eduardo Magalhães Rego, MD PhD, Guido Marcucci, Dan Douer, MD

Blood (2018) 132 (Supplement 1): 2816.

https://doi.org/10.1182/blood-2018-99-119962

Published: 2018

Journal Articles

T-Cell Lymphomas in Mexico: Experience of a Third Level Reference Hospital

Max Molina, MD, Natalia Vilches, MD, Oralia Barboza, MD PhD, Raquel Garza, MD PhD, Mauricio Román, UGRD, Veronica Pravia, UGRD, Juan Pablo Flores, MD PhD

Blood (2017) 130 (Supplement 1): 5191.

https://doi.org/10.1182/blood.V130.Suppl_1.5191.5191

Published: 2017

Journal Articles

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

Norihito Inoue, MD, Noriko Nishimura, MD PhD, Anna Takahashi, MD, Hirofumi Yamauchi, MD, Yoshiharu Kusano, MD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2016) 128 (22): 5360.

https://doi.org/10.1182/blood.V128.22.5360.5360

Published: 2016

Journal Articles

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

Aaron T Gerds, MD, Laura C Michaelis, MD, Danielle Shafer, DO

Blood (2010) 116 (21): 4913.

https://doi.org/10.1182/blood.V116.21.4913.4913

Published: 2010

Journal Articles

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

E. Mauricio Castellanos, M.D., Monika Metzger, L. Fulgencio Baez, Yessica Gamboa, Armando Pena Hernandez, Soad Alabi, Sandra Luna-Fineman, MD, Rosa Nieves, Pedro de Alarcon, MD

Blood (2009) 114 (22): 718.

https://doi.org/10.1182/blood.V114.22.718.718

Published: 2009

Journal Articles

T/NK “Nasal Type” Lymphomas: An Italian Cooperative Retrospective Survey.

Livio Pagano, MD, Andrea Gallamini, MD, Giulio Trapè, MD, Daniele Mattei, MD, Eros Di Bona, MD, Emilio Iannitto, MD, Antonio Spadea, MD, Elena Rossi, MD, Raffaele Tartaglione, MD, Maurizio Martelli, MD, Anna Maria Nosari, MD, Concetta Petti, MD, Paolo Falcucci, MD, Luigi Maria Larocca, MD, Giuseppe Leone, MD

Blood (2004) 104 (11): 4578.

https://doi.org/10.1182/blood.V104.11.4578.4578

Published: 2004

NARROW

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

T-Cell Lymphomas in Mexico: Experience of a Third Level Reference Hospital

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

T/NK “Nasal Type” Lymphomas: An Italian Cooperative Retrospective Survey.

Email alerts

ASH Publications

American Society of Hematology

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

T-Cell Lymphomas in Mexico: Experience of a Third Level Reference Hospital

Retrospective Analysis of NK/T Cell Lymphoma Prognostic Index (NKPI), EBV-DNA and Soluble IL-2 Receptor (sIL2R) for Extranodal NK/T-Cell Lymphoma, Nasal Type

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology.

T/NK “Nasal Type” Lymphomas: An Italian Cooperative Retrospective Survey.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only